{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:05:50Z","timestamp":1791911150396,"version":"4.3.4"},"reference-count":239,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.contraception.2012.12.011","type":"journal-article","created":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T18:16:04Z","timestamp":1357668964000},"page":"706-727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":191,"title":["Ethinyl estradiol and 17\u03b2-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment"],"prefix":"10.1016","volume":"87","author":[{"given":"Frank Z.","family":"Stanczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagu R.","family":"Bhavnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.12.011_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2008.02.020","article-title":"Oral contraceptives and individual variability of circulating levels of ethinyl estradiol and progestins","volume":"78","author":"Goldzieher","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0010","series-title":"Pharmacology of the contraceptive steroids","first-page":"5","article-title":"The progestins","author":"Perone","year":"1994"},{"key":"10.1016\/j.contraception.2012.12.011_bb0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115799","article-title":"Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease","volume":"133","author":"Gerstman","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0020","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/bmj.292.6519.526","article-title":"Oral contraceptives and venous thromboembolism: findings in a large prospective study","volume":"292","author":"Vessey","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.contraception.2012.12.011_bb0025","first-page":"CD003989","article-title":"20 \u03bcg versus >20 \u03bcg estrogen combined oral contraceptives for contraception","author":"Gallo","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2012.12.011_bb0030","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1471-0528.1979.tb11276.x","article-title":"Clinical trial of a new oral contraceptive pill containing the natural oestrogen 17 beta-oestradiol","volume":"86","author":"Astedt","year":"1979","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0035","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0140-6736(79)91525-3","article-title":"Natural oestrogens for oral contraception","volume":"2","author":"Serup","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.12.011_bb0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0010-7824(80)90010-4","article-title":"A randomized, double-blind study of two combined oral contraceptives continuing the same progestogen, but different estrogens","volume":"21","author":"World Health Organization Task Force on Oral Contraception","year":"1980","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1600-0412.1981.tb00038.x","article-title":"Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation","volume":"60","author":"Serup","year":"1981","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2012.12.011_bb0050","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3109\/00016348709015732","article-title":"Ovulation inhibition with 17 beta-estradiol cyclo-octyl acetate and desogestrel","volume":"66","author":"Schubert","year":"1987","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2012.12.011_bb0055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0378-5122(88)90023-0","article-title":"New natural oestradiol\/cyproterone acetate oral contraceptive for pre-menopausal women","volume":"10","author":"Hirvonen","year":"1988","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2012.12.011_bb0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0010-7824(96)00201-6","article-title":"The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17 beta-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days","volume":"54","author":"Csemiczky","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0378-5122(94)00856-3","article-title":"Oral contraceptive containing natural estradiol for premenopausal women","volume":"21","author":"Hirvonen","year":"1995","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2012.12.011_bb0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.contraception.2009.08.010","article-title":"Review of clinical experience with estradiol in combined oral contraceptives","volume":"81","author":"Fruzzetti","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0075","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.steroids.2011.02.002","article-title":"Nomegestrol acetate, a novel progestogen for oral contraception","volume":"76","author":"Mueck","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2012.12.011_bb0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/09513590903184167","article-title":"Why use of dienogest for the first contraceptive pill with estradiol?","volume":"26","author":"Mueck","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0085","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.contraception.2008.05.004","article-title":"Ovulation inhibition with four variations of a four-phasic estradiol valerate\/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies","volume":"78","author":"Endrikat","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0090","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.contraception.2009.03.018","article-title":"Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate\/dienogest and ethinyl estradiol\/levonorgestrel","volume":"80","author":"Ahrendt","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1783\/147118909788707878","article-title":"Qlaira: a \u2018natural\u2019 change of direction","volume":"35","author":"Mansour","year":"2009","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.12.011_bb0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejogrb.2009.11.001","article-title":"Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate\/dienogest): a Phase III trial","volume":"149","author":"Palacios","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0105","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/13625187.2011.614029","article-title":"Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol in a 24\/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21\/7 regimen","volume":"16","author":"Mansour","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.12.011_bb0110","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3109\/13625187.2010.504313","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17beta-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol","volume":"15","author":"Duijkers","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.12.011_bb0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/13625187.2011.554923","article-title":"Inhibition of ovulation by NOMAC\/E2, a novel monophasic oral contraceptive combining nomegestrol acetate and 17\u03b2-oestradiol: a double-blind, randomised, dose-finding pilot study","volume":"16","author":"Chabbert-Buffet","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.12.011_bb0120","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/humrep\/der058","article-title":"Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17\u03b2-estradiol (NOMAC\/E2): a double-blind, randomized study","volume":"26","author":"Christin-Maitre","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.12.011_bb0125","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/AOG.0b013e318250c3a0","article-title":"Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17beta-estradiol: a randomized controlled trial","volume":"119","author":"Westhoff","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0130","first-page":"53","article-title":"The neuroendocrine control of the menstrual cycle","volume":"36","author":"Knobil","year":"1980","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.contraception.2012.12.011_bb0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/oxfordjournals.humrep.a136365","article-title":"Dynamics of follicular growth in the human: a model from preliminary results","volume":"1","author":"Gougeon","year":"1986","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.12.011_bb0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/edrv-17-2-121","article-title":"Regulation of ovarian follicular development in primates: facts and hypotheses","volume":"17","author":"Gougeon","year":"1996","journal-title":"Endocr Rev"},{"key":"10.1016\/j.contraception.2012.12.011_bb0145","first-page":"1292","article-title":"The follicle-stimulating hormone (FSH) threshold\/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development","volume":"83","author":"Schipper","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.12.011_bb0150","series-title":"Progress in endocrinology: Excerpta Medica","first-page":"871","article-title":"Progesterone production","author":"Little","year":"1969"},{"key":"10.1016\/j.contraception.2012.12.011_bb0155","series-title":"Progress in endocrinology: Excerpta Medica","first-page":"770","article-title":"The utilization of plasma androstenedione for estrone production in women","author":"MacDonald","year":"1969"},{"key":"10.1016\/j.contraception.2012.12.011_bb0160","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1353\/pbm.1968.0053","article-title":"Steroid prehormones","volume":"11","author":"Baird","year":"1968","journal-title":"Perspect Biol Med"},{"key":"10.1016\/j.contraception.2012.12.011_bb0165","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1210\/jcem-29-2-149","article-title":"Concentration of unconjugated estrone and estradiol in peripheral plasma in nonpregnant women throughout the menstrual cycle, castrate and postmenopausal women and in men","volume":"29","author":"Baird","year":"1969","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.12.011_bb0170","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0015-0282(16)46511-8","article-title":"The role of lipoproteins in the regulation of progesterone secretion by the human corpus luteum","volume":"38","author":"Carr","year":"1982","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.12.011_bb0175","series-title":"Williams textbook of endocrinology","first-page":"581","article-title":"The physiology and pathology of the female reproductive axis","author":"Bulun","year":"2011"},{"key":"10.1016\/j.contraception.2012.12.011_bb0180","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1210\/edrv-9-4-396","article-title":"The saga of the ring B unsaturated equine estrogens","volume":"9","author":"Bhavnani","year":"1988","journal-title":"Endocr Rev"},{"key":"10.1016\/j.contraception.2012.12.011_bb0185","series-title":"Hormones, genes, and cancer","first-page":"12","article-title":"Biosynthesis, transport, and metabolism of steroid hormones","author":"Stanczyk","year":"2003"},{"key":"10.1016\/j.contraception.2012.12.011_bb0190","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1210\/en.2008-0304","article-title":"Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors (ERs) ERalpha and ERbeta","volume":"149","author":"Bhavnani","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.contraception.2012.12.011_bb0195","doi-asserted-by":"crossref","first-page":"26285","DOI":"10.1074\/jbc.273.41.26285","article-title":"Steroidogenic acute regulatory protein (StAR) is a sterol transfer protein","volume":"273","author":"Kallen","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.contraception.2012.12.011_bb0200","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0960-0760(98)00153-8","article-title":"Molecular pathology and mechanism of action of the steroidogenic acute regulatory protein, StAR","volume":"69","author":"Miller","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0205","first-page":"4243","article-title":"Localization of the steroidogenic acute regulatory protein in human tissues","volume":"82","author":"Pollack","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.12.011_bb0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0303-7207(99)00237-3","article-title":"Steroidogenic factor 1 (SF-1) is essential for ovarian development and function","volume":"163","author":"Hanley","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-4731(89)90296-3","article-title":"Human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid 5\u20134-ene-isomerase: purification from mitochondria and kinetic profiles, biophysical characterization of the purified mitochondrial and microsomal enzymes","volume":"33","author":"Thomas","year":"1989","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.contraception.2012.12.011_bb0220","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0021-9258(18)64294-2","article-title":"Biogenesis of estrogens by the human ovary. I. Conversion of acetate-1-C-14 to estrone and estradiol","volume":"236","author":"Ryan","year":"1961","journal-title":"J Biol Chem"},{"key":"10.1016\/j.contraception.2012.12.011_bb0225","first-page":"342","article-title":"Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis","volume":"15","author":"Simpson","year":"1994","journal-title":"Endocr Rev"},{"key":"10.1016\/j.contraception.2012.12.011_bb0230","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1210\/jcem-28-3-355","article-title":"Steroid formation by isolated and recombined ovarian granulosa and tehcal cells","volume":"28","author":"Ryan","year":"1968","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.12.011_bb0235","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1210\/jcem-35-4-627","article-title":"Conversion of androstenedione to estrone by human tissue","volume":"35","author":"Schindler","year":"1972","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.12.011_bb0240","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1210\/jcem-40-3-367","article-title":"Aromatization of androgens by human abdominal and breast fat tissue","volume":"40","author":"Nimrod","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.12.011_bb0245","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0022-4731(79)90514-4","article-title":"The interconversion and aromatization of androgens by human adipose tissue","volume":"10","author":"Perel","year":"1979","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.contraception.2012.12.011_bb0250","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1210\/jcem-40-3-413","article-title":"Aromatization of androstenedione by isolated human hairs","volume":"40","author":"Schweikert","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.12.011_bb0255","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1210\/jcem-43-4-785","article-title":"Aromatization of androstenedione by cultured human fibroblasts","volume":"43","author":"Schweikert","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.12.011_bb0260","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1210\/jcem-33-2-368","article-title":"Aromatization of androstenedione by the diencephalon","volume":"33","author":"Naftolin","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.12.011_bb0265","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1210\/jcem-46-1-146","article-title":"Aromatization of androgens by muscle and adipose tissue in vivo","volume":"46","author":"Longcope","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.12.011_bb0270","series-title":"Handbook of physiology","first-page":"615","article-title":"Role of extraglandular estrogen in human endocrinology","author":"Siiteri","year":"1973"},{"key":"10.1016\/j.contraception.2012.12.011_bb0275","first-page":"275","article-title":"Studies on the secretion and interconversion of the androgens","volume":"19","author":"Vandewiele","year":"1963","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.contraception.2012.12.011_bb0280","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000301332","article-title":"Plasma precursors of estrogen. III. Conversion of plasma dehydroisoandrosterone to estrogen in young nonpregnant women","volume":"7","author":"MacDonald","year":"1976","journal-title":"Gynecol Invest"},{"key":"10.1016\/j.contraception.2012.12.011_bb0285","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1172\/JCI105718","article-title":"Metabolic clearance rates and interconversions of estrone and 17beta-estradiol in normal males and females","volume":"47","author":"Longcope","year":"1968","journal-title":"J Clin Invest"},{"key":"10.1016\/j.contraception.2012.12.011_bb0290","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2265.1974.tb03298.x","article-title":"Sex-hormone-binding globulin","volume":"3","author":"Anderson","year":"1974","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.contraception.2012.12.011_bb0295","first-page":"457","article-title":"The serum transport of steroid hormones","volume":"38","author":"Siiteri","year":"1982","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.contraception.2012.12.011_bb0300","first-page":"250","article-title":"Steroid Binding to Human SBP","volume":"Vol 27","author":"Westphal","year":"1986"},{"key":"10.1016\/j.contraception.2012.12.011_bb0305","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1210\/edrv-2-1-103","article-title":"Transport of protein-bound hormones into tissues in vivo","volume":"2","author":"Pardridge","year":"1981","journal-title":"Endocr Rev"},{"key":"10.1016\/j.contraception.2012.12.011_bb0310","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1210\/jcem-43-2-436","article-title":"Free and protein-bound plasma estradiol-17 beta during the menstrual cycle","volume":"43","author":"Wu","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.12.011_bb0315","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jcem-61-3-499","article-title":"Transport of equine estrogens: binding of conjugated and unconjugated equine estrogens with human serum proteins","volume":"61","author":"Pan","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl. 2","key":"10.1016\/j.contraception.2012.12.011_bb0320","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/sj.ijo.0801282","article-title":"Obesity, insulin, sex steroids and ovulation","volume":"24","author":"Nestler","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.contraception.2012.12.011_bb0325","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ajcn\/45.1.277","article-title":"Adipose tissue as a source of hormones","volume":"45","author":"Siiteri","year":"1987","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.contraception.2012.12.011_bb0330","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3181\/00379727-217-44199","article-title":"Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism","volume":"217","author":"Bhavnani","year":"1998","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.contraception.2012.12.011_bb0335","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0960-0760(03)00377-7","article-title":"Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis","volume":"86","author":"Yue","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0340","series-title":"Catechol estrogens","first-page":"123","article-title":"Active metabolites and carcinogenesis","author":"Purdy","year":"1983"},{"key":"10.1016\/j.contraception.2012.12.011_bb0345","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/edrv-11-4-524","article-title":"Estrogen carcinogenesis in hamster tissues: a critical review","volume":"11","author":"Li","year":"1990","journal-title":"Endocr Rev"},{"key":"10.1016\/j.contraception.2012.12.011_bb0350","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1210\/endo.132.2.8381068","article-title":"The carcinogenic activity of ethinyl estrogens is determined by both their hormonal characteristics and their conversion to catechol metabolites","volume":"132","author":"Zhu","year":"1993","journal-title":"Endocrinology"},{"issue":"Suppl.","key":"10.1016\/j.contraception.2012.12.011_bb0355","first-page":"S259","article-title":"2-Hydroxyestrone: the \u2018good\u2019 estrogen","volume":"150","author":"Bradlow","year":"1996","journal-title":"J Endocrinol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0360","first-page":"63","article-title":"Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention","volume":"1766","author":"Cavalieri","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.contraception.2012.12.011_bb0365","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.79.9.3047","article-title":"Abnormal oxidative metabolism of estradiol in women with breast cancer","volume":"79","author":"Schneider","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.contraception.2012.12.011_bb0370","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.1073\/pnas.82.18.6295","article-title":"Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans","volume":"82","author":"Bradlow","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.contraception.2012.12.011_bb0375","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1021\/bi00348a027","article-title":"Interaction of histones with estrogens. Covalent adduct formation with 16 alpha-hydroxyestrone","volume":"24","author":"Yu","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.contraception.2012.12.011_bb0380","doi-asserted-by":"crossref","first-page":"7831","DOI":"10.1073\/pnas.85.21.7831","article-title":"Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization","volume":"85","author":"Swaneck","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.contraception.2012.12.011_bb0385","first-page":"505","article-title":"Urinary estrogen metabolites and breast cancer: a case\u2013control study","volume":"6","author":"Kabat","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.contraception.2012.12.011_bb0390","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00001648-200011000-00004","article-title":"Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women","volume":"11","author":"Muti","year":"2000","journal-title":"Epidemiology"},{"issue":"Suppl. 3","key":"10.1016\/j.contraception.2012.12.011_bb0395","first-page":"601","article-title":"A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer","volume":"105","author":"Ursin","year":"1997","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.contraception.2012.12.011_bb0400","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/jnci\/91.12.1067","article-title":"Urinary 2-hydroxyestrone\/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women","volume":"91","author":"Ursin","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.contraception.2012.12.011_bb0405","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1014896417653","article-title":"Urinary 2-hydroxyestrone\/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women","volume":"72","author":"Ursin","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.contraception.2012.12.011_bb0410","first-page":"3326","article-title":"Do urinary estrogen metabolites reflect the differences in breast cancer risk between Singapore Chinese and United States African-American and white women?","volume":"61","author":"Ursin","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.contraception.2012.12.011_bb0415","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1210\/jcem-29-1-41","article-title":"Intermediates in the transformation of oral estradiol","volume":"29","author":"Fishman","year":"1969","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.12.011_bb0420","first-page":"966","article-title":"Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17 beta-estradiol","volume":"43","author":"Kuhnz","year":"1993","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.contraception.2012.12.011_bb0425","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/03639048109051946","article-title":"Bioavailability of four oestradiol suspensions with different particle sizes - in vivo\/in vitro correlation","volume":"7","author":"Kvorning","year":"1981","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.contraception.2012.12.011_bb0430","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0022-4731(85)90068-8","article-title":"The metabolism of estradiol; oral compared to intravenous administration","volume":"23","author":"Longcope","year":"1985","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.contraception.2012.12.011_bb0435","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0022-4731(80)90196-X","article-title":"Biliary excretion and intestinal metabolism of progesterone and estrogens in man","volume":"13","author":"Adlercreutz","year":"1980","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.contraception.2012.12.011_bb0440","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0010-7824(79)90094-5","article-title":"Steroid absorption and enterohepatic recycling","volume":"20","author":"Adlercreutz","year":"1979","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0445","series-title":"Estrogens and antiestrogens II","first-page":"261","article-title":"Pharmacokinetics of exogenous natural and synthetic estrogens and antiestrogens","author":"Kuhnz","year":"1999"},{"key":"10.1016\/j.contraception.2012.12.011_bb0450","series-title":"Reproductive endocrinology, infertility and genetics","article-title":"Estrogen metabolism","author":"Buster","year":"1987"},{"key":"10.1016\/j.contraception.2012.12.011_bb0455","first-page":"17","article-title":"Estrogens used for replacement therapy in postmenopausal women","volume":"15","author":"Stanczyk","year":"2001","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0460","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000180039","article-title":"Pharmacokinetics and biotransformation of estradiol valerate in ovariectomized women","volume":"21","author":"Dusterberg","year":"1985","journal-title":"Horm Res"},{"key":"10.1016\/j.contraception.2012.12.011_bb0465","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0378-5122(82)90064-0","article-title":"Pharmacokinetic and pharmacological features of oestradiol valerate","volume":"4","author":"Dusterberg","year":"1982","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2012.12.011_bb0470","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1172\/JCI103524","article-title":"Studies on phenolic steroids in human subjects. II. The metabolic fate and hepato-biliary-enteric circulation of C14-estrone and C14-estradiol in women","volume":"36","author":"Sandberg","year":"1957","journal-title":"J Clin Invest"},{"key":"10.1016\/j.contraception.2012.12.011_bb0475","first-page":"133","article-title":"Pharmacokinetics of ethynyloestradiol in humans","volume":"4","author":"Fotherby","year":"1982","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0480","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0163-7258(89)90121-6","article-title":"Interindividual variation in the metabolism of ethynylestradiol","volume":"43","author":"Orme","year":"1989","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.contraception.2012.12.011_bb0485","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0010-7824(89)90092-9","article-title":"Pharmacokinetics of three bioequivalent norethindrone\/mestranol-50 micrograms and three norethindrone\/ethinyl estradiol-35 micrograms OC formulations: are \u201clow-dose\u201d pills really lower?","volume":"40","author":"Brody","year":"1989","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0490","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0022-4731(90)90290-9","article-title":"Protein binding of the contraceptive steroids gestodene, 3-keto-desogestrel and ethinylestradiol in human serum","volume":"35","author":"Kuhnz","year":"1990","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.contraception.2012.12.011_bb0495","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0010-7824(93)90043-7","article-title":"Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol","volume":"47","author":"Hammerstein","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0500","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0010-7824(81)90062-7","article-title":"Plasma levels of ethinylestradiol (EE) during cyclic treatment with combined oral contraceptives","volume":"24","author":"Kaufman","year":"1981","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0505","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/0024-3205(90)90431-P","article-title":"Metabolism of 17 alpha-ethynylestradiol in humans","volume":"47","author":"Guengerich","year":"1990","journal-title":"Life Sci"},{"key":"10.1016\/j.contraception.2012.12.011_bb0510","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0002-9378(89)80010-9","article-title":"Pharmacology of contraceptive steroids: a brief review","volume":"160","author":"Goldzieher","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0515","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0010-7824(76)90083-4","article-title":"Bio-availability and pharmacokinetics of cyproterone acetate-14C and ethinyloestradiol-3H after oral administration as a coated tablet (SH B 209 AB)","volume":"14","author":"Speck","year":"1976","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0520","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1677\/joe.0.0550351","article-title":"Metabolism of ethynyloestradiol in man","volume":"55","author":"Reed","year":"1972","journal-title":"J Endocrinol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0525","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1210\/jcem-29-8-1051","article-title":"Fate of ingested radiolabeled ethynylestradiol and its 3-cyclopentyl ether in patients with bile fistulas","volume":"29","author":"Cargill","year":"1969","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.12.011_bb0530","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1124\/pr.58.4.8","article-title":"International Union of Pharmacology. LXIV. Estrogen receptors","volume":"58","author":"Dahlman-Wright","year":"2006","journal-title":"Pharmacol Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2012.12.011_bb0535","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.maturitas.2004.03.006","article-title":"The molecular determinants of estrogen receptor pharmacology","volume":"48","author":"McDonnell","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2012.12.011_bb0540","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1073\/pnas.93.12.5925","article-title":"Cloning of a novel receptor expressed in rat prostate and ovary","volume":"93","author":"Kuiper","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.contraception.2012.12.011_bb0545","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.3283939","article-title":"The steroid and thyroid hormone receptor superfamily","volume":"240","author":"Evans","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.contraception.2012.12.011_bb0550","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.contraception.2012.12.011_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10409230290771438","article-title":"Biological role of estrogen and estrogen receptors","volume":"37","author":"Nilsson","year":"2002","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0560","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1210\/endo-108-4-1511","article-title":"17 Alpha-ethinyl estradiol is more potent than estradiol in receptor interactions with isolated hepatic parenchymal cells","volume":"108","author":"Dickson","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.contraception.2012.12.011_bb0565","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1056\/NEJM198304143081502","article-title":"Effect of estrogen\/progestin potency on lipid\/lipoprotein cholesterol","volume":"308","author":"Wahl","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2012.12.011_bb0570","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/0002-9378(88)90199-8","article-title":"Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins","volume":"158","author":"Crook","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0575","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","article-title":"The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism","volume":"323","author":"Godsland","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2012.12.011_bb0580","first-page":"33","article-title":"Lipid and lipoprotein changes associated with oral contraceptive use: a randomized clinical trial","volume":"71","author":"Burkman","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0585","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0002-9378(89)80012-2","article-title":"Lipid and lipoprotein changes in women taking low-dose, triphasic oral contraceptives: a controlled, comparative, 12-month clinical trial","volume":"160","author":"Notelovitz","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0590","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/0002-9378(89)90703-5","article-title":"The effect of triphasic oral contraceptives on plasma lipids and lipoproteins","volume":"161","author":"Patsch","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0595","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0002-9378(90)90582-R","article-title":"Estrogenic effect of gestodene- or desogestrel-containing oral contraceptives on lipoprotein metabolism","volume":"163","author":"Gevers Leuven","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0600","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0002-9378(90)90584-T","article-title":"Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyl estradiol on lipid metabolism in comparison with two levonorgestrel preparations","volume":"163","author":"Kloosterboer","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0605","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9378(99)70365-0","article-title":"Effects of low-dose monophasic levonorgestrel with ethinyl estradiol preparation on serum lipid levels: a twenty-four month clinical trial","volume":"181","author":"Young","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl. 2","key":"10.1016\/j.contraception.2012.12.011_bb0610","first-page":"98","article-title":"Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel","volume":"40","author":"Teichmann","year":"1995","journal-title":"Int J Fertil Menopausal Stud"},{"key":"10.1016\/j.contraception.2012.12.011_bb0615","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0010-7824(98)00018-3","article-title":"Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism","volume":"57","author":"Crook","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.eurheartj.a061365","article-title":"Coronary atherosclerosis and myocardial infarction in young women\u2013role of oral contraceptives","volume":"4","author":"Engel","year":"1983","journal-title":"Eur Heart J"},{"key":"10.1016\/j.contraception.2012.12.011_bb0625","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0002-8703(83)90100-X","article-title":"Myocardial infarction, oral contraception, cigarette smoking, and coronary artery spasm in young women","volume":"106","author":"Jugdutt","year":"1983","journal-title":"Am Heart J"},{"key":"10.1016\/j.contraception.2012.12.011_bb0630","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/bmj.298.6667.165","article-title":"Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study","volume":"298","author":"Croft","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2012.12.011_bb0635","first-page":"1034","article-title":"Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins","volume":"81","author":"Speroff","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0640","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0010-7824(97)00118-2","article-title":"The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women","volume":"56","author":"Lewis","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0645","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1001\/jama.1985.03350440043028","article-title":"Myocardial infarction and cigarette smoking in women younger than 50 years of age","volume":"253","author":"Rosenberg","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2012.12.011_bb0650","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJM199106063242303","article-title":"Smoking and mortality among older men and women in three communities","volume":"324","author":"LaCroix","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2012.12.011_bb0655","doi-asserted-by":"crossref","first-page":"S383","DOI":"10.1016\/S0002-9378(99)70700-3","article-title":"Oral contraceptives and smoking, current considerations: recommendations of a consensus panel","volume":"180","author":"Schiff","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0660","first-page":"1","article-title":"U S. medical eligibility criteria for contraceptive use","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR"},{"key":"10.1016\/j.contraception.2012.12.011_bb0665","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.21059","article-title":"Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use","volume":"83","author":"Pomp","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0670","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/13625187.2011.604450","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol in comparison to levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism","volume":"16","author":"\u00c5gren","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.12.011_bb0675","first-page":"796","article-title":"Metabolic effects of Envoid in rheumatoid patients","volume":"6","author":"Waine","year":"1963","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.contraception.2012.12.011_bb0680","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0140-6736(79)92949-0","article-title":"Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism","volume":"1","author":"Wynn","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.12.011_bb0685","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0002-9378(90)90578-U","article-title":"Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease","volume":"163","author":"Gaspard","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0690","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2337\/diacare.20.3.330","article-title":"A prospective study of oral contraceptives and NIDDM among U.S. women","volume":"20","author":"Chasan-Taber","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.contraception.2012.12.011_bb0695","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1067\/mob.2000.105909","article-title":"Oral contraceptive use and glucose metabolism in a national sample of women in the united states","volume":"183","author":"Troisi","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0700","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0010-7824(01)00316-X","article-title":"An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables","volume":"65","author":"Endrikat","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0705","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.contraception.2004.08.017","article-title":"A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel","volume":"71","author":"Skouby","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0710","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1124\/pr.107.08002","article-title":"Vascular actions of estrogens: functional implications","volume":"60","author":"Miller","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.contraception.2012.12.011_bb0715","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.vph.2011.06.003","article-title":"The G protein-coupled estrogen receptor GPER\/GPR30 as a regulator of cardiovascular function","volume":"55","author":"Meyer","year":"2011","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0720","doi-asserted-by":"crossref","first-page":"936","DOI":"10.7326\/0003-4819-121-12-199412150-00005","article-title":"Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women","volume":"121","author":"Lieberman","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.contraception.2012.12.011_bb0725","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1161\/ATVBAHA.107.145383","article-title":"Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women","volume":"27","author":"Sherwood","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0730","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0002-9378(00)37848-6","article-title":"Effects of oral contraceptives on vascular endothelium in premenopausal women","volume":"183","author":"John","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0735","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0010-7824(01)00287-6","article-title":"Effect of two oral contraceptives with different ethinyl estradiol and levonorgestrel concentrations on the urinary excretion of biochemical vasoactive markers","volume":"64","author":"Mueck","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0740","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1471-0528.1986.tb08669.x","article-title":"Blood pressure alters during the normal menstrual cycle","volume":"93","author":"Kelleher","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0745","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.94.3.483","article-title":"Prospective study of oral contraceptives and hypertension among women in the United States","volume":"94","author":"Chasan-Taber","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.contraception.2012.12.011_bb0750","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0010-7824(86)90034-X","article-title":"The effect of the contraceptive pill on blood pressure: a randomized controlled trial of three progestogen-oestrogen combinations in Szeged, Hungary","volume":"33","author":"Kovacs","year":"1986","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0755","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0010-7824(93)90034-5","article-title":"Effect of four combined oral contraceptives on blood pressure in the pill-free interval","volume":"47","author":"Nichols","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0760","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0002-9378(16)32484-X","article-title":"Oral contraceptives, clotting factors, and thrombosis","volume":"142","author":"Meade","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0765","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0002-9378(90)90590-4","article-title":"Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid","volume":"163","author":"Jespersen","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0770","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0002-9378(11)91697-4","article-title":"Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial","volume":"167","author":"Notelovitz","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0775","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0010-7824(94)00002-E","article-title":"Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives","volume":"51","author":"Schlit","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0780","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0010-7824(02)00476-6","article-title":"The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study","volume":"67","author":"Oral Contraceptive and Hemostasis Study Group","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0785","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1160\/TH10-05-0327","article-title":"Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate\/17beta-estradiol, compared with those of levonorgestrel\/ethinyl estradiol. A double-blind, randomised study","volume":"105","author":"Gaussem","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2012.12.011_bb0790","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2165\/11590220-000000000-00000","article-title":"Metabolic and haemostatic effects of estradiol valerate\/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study","volume":"31","author":"Junge","year":"2011","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.contraception.2012.12.011_bb0795","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0010-7824(94)90099-X","article-title":"Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives","volume":"49","author":"Fruzzetti","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0800","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1016\/S0002-9378(99)70698-8","article-title":"Hemostatic effects of smoking and oral contraceptive use","volume":"180","author":"Fruzzetti","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0805","first-page":"157","article-title":"Endocrine regulation of the growth plate","volume":"64","author":"Nilsson","year":"2005","journal-title":"Horm Res"},{"key":"10.1016\/j.contraception.2012.12.011_bb0810","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/jama.290.8.1042","article-title":"Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial","volume":"290","author":"Prestwood","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2012.12.011_bb0815","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S8756-3282(99)00076-9","article-title":"A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group","volume":"24","author":"Delmas","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.contraception.2012.12.011_bb0820","first-page":"330","article-title":"A randomized controlled trial of four doses of transdermal estradiol for preventing postmenopausal bone loss. Transdermal Estradiol Investigator Group","volume":"94","author":"Weiss","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0825","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.AOG.0000137833.43248.79","article-title":"Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial","volume":"104","author":"Ettinger","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0830","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.maturitas.2007.03.005","article-title":"The effect of transvaginal estradiol on bone in aged women: a randomised controlled trial","volume":"57","author":"Salminen","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2012.12.011_bb0835","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF01880410","article-title":"Estrogens, bone loss and preservation","volume":"1","author":"Christiansen","year":"1990","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.contraception.2012.12.011_bb0840","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.3388021","article-title":"Evidence of estrogen receptors in normal human osteoblast-like cells","volume":"241","author":"Eriksen","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.contraception.2012.12.011_bb0845","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jpag.2009.11.001","article-title":"Low-dose oral contraceptives in adolescents: how low can you go?","volume":"23","author":"Agostino","year":"2010","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0850","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11914-010-0037-9","article-title":"Oral contraceptive use and bone","volume":"9","author":"Wei","year":"2011","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.contraception.2012.12.011_bb0855","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1600-0412.2012.01498.x","article-title":"Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate\/17beta-estradiol in comparison to levonorgestrel\/ethinylestradiol","volume":"91","author":"Sordal","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2012.12.011_bb0860","series-title":"Pharmacology of the contraceptive steroids","first-page":"283","article-title":"Nervous system","author":"Keefe","year":"1994"},{"key":"10.1016\/j.contraception.2012.12.011_bb0865","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1212\/WNL.21.8.853","article-title":"The role of progesterone in menstrual migraine","volume":"21","author":"Somerville","year":"1971","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2012.12.011_bb0870","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11916-012-0293-8","article-title":"Transdermal hormonal therapy in perimenstrual migraine: why, when and how?","volume":"16","author":"Tassorelli","year":"2012","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.contraception.2012.12.011_bb0875","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1479-828X.1973.tb02291.x","article-title":"The relationship of oral contraception to depressive symptoms","volume":"13","author":"Leeton","year":"1973","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0880","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1093\/humrep\/der269","article-title":"Hormonal contraception and mental health: results of a population-based study","volume":"26","author":"Toffol","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.12.011_bb0885","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0010-7824(97)00023-1","article-title":"Combined oral contraceptives and liver disease","volume":"55","author":"Hannaford","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0890","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9378(82)90218-6","article-title":"Comparison of pharmacodynamic properties of various estrogen formulations","volume":"144","author":"Mashchak","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0895","first-page":"CD004425","article-title":"Combined oral contraceptive pills for treatment of acne","volume":"7","author":"Arowojolu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2012.12.011_bb0900","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0010-7824(99)00093-1","article-title":"Effect of low-dose oral contraceptives on androgenic markers and acne","volume":"60","author":"Thorneycroft","year":"1999","journal-title":"Contraception"},{"issue":"771\u20132","key":"10.1016\/j.contraception.2012.12.011_bb0905","first-page":"783","article-title":"Reproductive dysfunction in women with epilepsy: antiepileptic drug effects on sex-steroid hormones","volume":"6","author":"Morrell","year":"2001","journal-title":"CNS Spectr"},{"key":"10.1016\/j.contraception.2012.12.011_bb0910","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.yebeh.2011.05.001","article-title":"Normal vitamin D and low free estradiol levels in women on enzyme-inducing antiepileptic drugs","volume":"21","author":"Pack","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.contraception.2012.12.011_bb0915","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2010.06.013","article-title":"The use of hormonal contraception among women taking anticonvulsant therapy","volume":"83","author":"Gaffield","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0920","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1528-1167.2005.10105.x","article-title":"Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations","volume":"46","author":"Reimers","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2012.12.011_bb0925","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1067\/mjd.2002.120448","article-title":"Oral contraceptive efficacy and antibiotic interaction: a myth debunked","volume":"46","author":"Archer","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0930","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.contraception.2010.08.020","article-title":"Antibiotics and oral contraceptive failure \u2014 a case\u2013crossover study","volume":"83","author":"Toh","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0935","first-page":"853","article-title":"Drug interactions between oral contraceptives and antibiotics","volume":"98","author":"Dickinson","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0940","first-page":"105","article-title":"The effects of smoking on estradiol metabolism","volume":"56","author":"Tansavatdi","year":"2004","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0945","first-page":"1","article-title":"Smoking, estradiol metabolism and hormone replacement therapy","volume":"53","author":"Mueck","year":"2003","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.contraception.2012.12.011_bb0950","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.clpt.2006.01.008","article-title":"Female sex and oral contraceptive use accelerate nicotine metabolism","volume":"79","author":"Benowitz","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.contraception.2012.12.011_bb0955","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0010-7824(98)00148-6","article-title":"Effect of oral contraceptives containing 20 and 35 micrograms ethinyl estradiol on urinary prostacyclin and thromboxane metabolite levels in smokers and nonsmokers","volume":"59","author":"Stanczyk","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0960","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2125.1998.00749.x","article-title":"Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers","volume":"46","author":"Ouellet","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2012.12.011_bb0965","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1097\/QAI.0b013e31822b8bf8","article-title":"Combined oral contraceptives and antiretroviral PK\/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi","volume":"58","author":"Stuart","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2012.12.011_bb0970","first-page":"32","article-title":"\u201cThe rabbits are prepared \u2026\u201d \u2014 The development of ethinylestradiol and ethinyl testosterone","volume":"8","author":"Frobenius","year":"2011","journal-title":"J Reprod Med Endo"},{"key":"10.1016\/j.contraception.2012.12.011_bb0975","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0010-7824(99)00109-2","article-title":"Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations","volume":"60","author":"Rosenberg","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0980","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/13625180701536771","article-title":"The effects of an oestrogen-free, desogestrel-containing oral contraceptive in women with cyclical symptoms: results from two studies on oestrogen-related symptoms and dysmenorrhoea","volume":"12","author":"Ahrendt","year":"2007","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.12.011_bb0985","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0010-7824(01)00306-7","article-title":"Contraceptives and cerebral thrombosis: a five-year national case\u2013control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb0990","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.12.011_bb0995","first-page":"4","article-title":"Recent studies confirm the safety of oral contraceptives with respect to stroke","volume":"7","year":"1996","journal-title":"Contracept Rep"},{"key":"10.1016\/j.contraception.2012.12.011_bb1000","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0010-7824(98)00016-X","article-title":"Oral contraceptive use and myocardial infarction","volume":"57","author":"Petitti","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb1005","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb1010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0010-7824(97)00119-4","article-title":"First-time use of newer oral contraceptives and the risk of venous thromboembolism","volume":"56","author":"Suissa","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb1015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2141.2007.06780.x","article-title":"Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations","volume":"139","author":"Pomp","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.contraception.2012.12.011_bb1020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/107602960401000308","article-title":"Effect of age on oral contraceptive-induced venous thrombosis","volume":"10","author":"Girolami","year":"2004","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.contraception.2012.12.011_bb1025","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2012.12.011_bb1030","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case\u2013control study","volume":"339","author":"van Hylckama","year":"2009","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2012.12.011_bb1035","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/humrep\/15.4.817","article-title":"Recurrent use of newer oral contraceptives and the risk of venous thromboembolism","volume":"15","author":"Suissa","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.12.011_bb1040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(96)07496-X","article-title":"Population-based study of risk of venous thromboembolism associated with various oral contraceptives","volume":"349","author":"Farmer","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.12.011_bb1045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0010-7824(98)00002-X","article-title":"The risks of venous thromboembolic disease among German women using oral contraceptives: a database study","volume":"57","author":"Farmer","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb1050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1783\/147118910793048665","article-title":"50 years of \u201cThe Pill\u201d: celebrating a golden anniversary","volume":"36","author":"Szarewski","year":"2010","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.12.011_bb1055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1783\/147118910790291037","article-title":"Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies","volume":"36","author":"Shapiro","year":"2010","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.12.011_bb1060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1783\/147118910791749425","article-title":"Oral contraceptives and venous thromboembolism consensus opinion from an international workshop held in Berlin, Germany in December 2009","volume":"36","author":"Reid","year":"2010","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.12.011_bb1065","first-page":"630","article-title":"Appearance of mammary cancers in male mice subjected to folliculin injections","volume":"195","author":"Lacassagne","year":"1932","journal-title":"Comptes Rendus de l'Academie des Sciences"},{"key":"10.1016\/j.contraception.2012.12.011_bb1070","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0140-6736(01)72307-0","article-title":"On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases","volume":"2","author":"Beatson","year":"1896","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.12.011_bb1075","first-page":"605","article-title":"Menopause and breast cancer risk","volume":"48","author":"Trichopoulos","year":"1972","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.contraception.2012.12.011_bb1080","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/aje\/152.10.950","article-title":"Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study","volume":"152","author":"Colditz","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2012.12.011_bb1085","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/S0010-7824(15)30002-0","article-title":"Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer","volume":"54","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb1090","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.12.011_bb1095","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/oxfordjournals.aje.a116464","article-title":"A case\u2013control study of the risk of breast cancer in relation to oral contraceptive use","volume":"136","author":"Rosenberg","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2012.12.011_bb1100","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","article-title":"Oral contraceptives and the risk of breast cancer","volume":"346","author":"Marchbanks","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2012.12.011_bb1105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/oxfordjournals.epirev.a036233","article-title":"The epidemiology of benign breast disease","volume":"3","author":"Ernster","year":"1981","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.contraception.2012.12.011_bb1110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01806008","article-title":"Epidemiology and endocrinology of benign breast disease","volume":"6","author":"Wang","year":"1985","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.contraception.2012.12.011_bb1115","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.aje.a113089","article-title":"Risk factors for benign breast disease","volume":"113","author":"Brinton","year":"1981","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2012.12.011_bb1120","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ijc.2910500612","article-title":"Oral contraceptives and risk of benign proliferative epithelial disorders of the breast","volume":"50","author":"Rohan","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2012.12.011_bb1125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<191::AID-IJC7>3.0.CO;2-F","article-title":"A cohort study of oral contraceptive use and risk of benign breast disease","volume":"82","author":"Rohan","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2012.12.011_bb1130","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.contraception.2007.08.011","article-title":"Oral contraceptives and benign breast disease: an update of findings in a large cohort study","volume":"76","author":"Vessey","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.12.011_bb1135","first-page":"3678","article-title":"Does oral contraceptive use increase the risk of breast cancer in women with BRCA1\/BRCA2 mutations more than in other women?","volume":"57","author":"Ursin","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.contraception.2012.12.011_bb1140","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/jnci\/94.23.1773","article-title":"Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"94","author":"Narod","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.contraception.2012.12.011_bb1145","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/1055-9965.EPI-04-0376","article-title":"Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations","volume":"14","author":"Milne","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.contraception.2012.12.011_bb1150","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/bmj.299.6714.1487","article-title":"Mortality among oral contraceptive users: 20 year follow up of women in a cohort study","volume":"299","author":"Vessey","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2012.12.011_bb1155","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1158\/1055-9965.EPI-07-0053","article-title":"Oral contraceptives and survival in breast cancer patients aged 20 to 54 years","volume":"16","author":"Trivers","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.contraception.2012.12.011_bb1160","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/01.AOG.0000284446.22251.6e","article-title":"Oral contraceptives and the risk of death from breast cancer","volume":"110","author":"Wingo","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.12.011_bb1165","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/oxfordjournals.aje.a010135","article-title":"Bias in the evaluation of low-magnitude associations: an empirical perspective","volume":"151","author":"Shapiro","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2012.12.011_bb1170","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1517\/14656566.9.13.2317","article-title":"Non-contraceptive benefits of oral contraceptives","volume":"9","author":"Huber","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.contraception.2012.12.011_bb1175","doi-asserted-by":"crossref","first-page":"R263","DOI":"10.1677\/ERC-10-0076","article-title":"Hormonal contraception and risk of endometrial cancer: a systematic review","volume":"17","author":"Mueck","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.contraception.2012.12.011_bb1180","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1056\/NEJM198703123161102","article-title":"The reduction in risk of ovarian cancer associated with oral-contraceptive use. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2012.12.011_bb1185","series-title":"Clinical gynecologic endocrinology and infertility","first-page":"691","year":"2005"},{"key":"10.1016\/j.contraception.2012.12.011_bb1190","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies","volume":"370","author":"Appleby","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.12.011_bb1195","doi-asserted-by":"crossref","first-page":"c927","DOI":"10.1136\/bmj.c927","article-title":"Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study","volume":"340","author":"Hannaford","year":"2010","journal-title":"BMJ"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412010797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412010797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:11:43Z","timestamp":1757880703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412010797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":239,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0010782412010797"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.12.011","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethinyl estradiol and 17\u03b2-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2012.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}